ANG Lifesciences India Limited

Equities

ANG6

INE236W01016

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:50 2024-04-26 am EDT 5-day change 1st Jan Change
57.2 INR -0.33% Intraday chart for ANG Lifesciences India Limited +0.37% -17.59%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
ANG Lifesciences India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
ANG Lifesciences India CFO Steps Down MT
ANG Lifesciences India Limited Announces Resignation of Neeraj Gupta as Chief Financial Officer CI
ANG Lifesciences India Limited Appoints Rohit Mittal as Additional Director (Non-Executive Non Independent Director) CI
ANG Lifesciences India Limited Informs Mrs. Sudesh Kumari Resigns as Non-Executive Non Independent Director CI
ANG Lifesciences India Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
ANG Lifesciences India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
ANG Lifesciences India Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
ANG Lifesciences India Limited Appoints Neeraj Gupta as the CFO CI
ANG Lifesciences India Limited announced that it expects to receive INR 60.5 million in funding from ANG Capital Investments Private Limited CI
ANG Lifesciences India Limited announced that it expects to receive INR 60.5 million in funding from ANG Capital Investments Private Limited CI
ANG Lifesciences India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
ANG Lifesciences India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
ANG Lifesciences India CFO Resigns MT
ANG Lifesciences India Limited Announces Resignation of Subodh Sharma as Chief Financial Officer CI
ANG Lifesciences India Limited announced that it expects to receive INR 20 million in funding CI
ANG Lifesciences India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Infomerics Valuation Raises Rating on ANG Lifesciences India's Long-term Bank Financing; Outlook Stable MT
ANG Lifesciences India Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
ANG Lifesciences Gets BSE Nod for Bonus Issue of Shares MT
ANG Lifesciences India Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
ANG Lifesciences India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
ANG Lifesciences Board to Consider Issuance of Bonus Shares; Shares Jump 5% MT
ANG Lifesciences India Limited Approves Re-Constitution of Committee CI
ANG Lifesciences India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Chart ANG Lifesciences India Limited
More charts
ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and printing and packagings. The Company's products portfolio includes various products comprising therapeutic categories, such as Antibiotics, Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid, Penicillin and Beta Lactamase Inhibitor. It is engaged in the business of manufacturing and sales of finished pharmaceutical formulations in a dosage form of Dry Powder Injection Vials, Liquid Injections Vials, Ampoules, PFS, Hard Gelatin Capsules, Tablets, Soft Gelatin Capsules, Dry Syrups, Liquid Syru ps and Suspension, and Lotions, among others. The Company's subsidiaries include ANG Lifesciences India Limited and Mansa Prints and Publishers Limited.
More about the company